AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-1.97 Cr | ₹-2.64 Cr | ₹1.95 Cr | ₹-4.21 Cr | ₹3.49 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AMBALAL SARABHAI ENTERPRISES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2023 | ₹-1.97 Cr |
Mar2022 | ₹-2.64 Cr |
Mar2021 | ₹1.95 Cr |
Mar2020 | ₹-4.21 Cr |
Mar2019 | ₹3.49 Cr |
How is Net Cash Inflow / Outflow of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2023 | ₹-1.97 Cr | Negative | |
Mar2022 | ₹-2.64 Cr | Negative | |
Mar2021 | ₹1.95 Cr | Positive | |
Mar2020 | ₹-4.21 Cr | Negative | |
Mar2019 | ₹3.49 Cr | - |
Compare Net Cash Inflow / Outflow of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹348.3 Cr | -2.9% | -5.7% | 108.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | -2.9% |
-5.7% |
108.2% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses